Citations for
1TPM3
Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis.
Yu SB, Gao Q, Lin WW, Kang MQ.
Mol Med Rep 15(3):1236-1242. doi: 10.3892/mmr.2017.6145. Epub 2017 Jan 25. 2017
2TPM3
TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype.
Donkervoort S, Papadaki M, de Winter JM, Neu MB, Kirschner J, Bolduc V, Yang ML, Gibbons MA, Hu Y, Dastgir J, Leach ME, Rutkowski A, Foley AR, Krüger M, Wartchow EP, McNamara E, Ong R, Nowak KJ, Laing NG, Clarke NF, Ottenheijm C, Marston SB, Bönnemann CG.
Ann Neurol 78(6):982-994. doi: 10.1002/ana.24535. Epub 2015 Nov 13. 2015
3CFTD3, TPM3
Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.
Yuen M, Cooper ST, Marston SB, Nowak KJ, McNamara E, Mokbel N, Ilkovski B, Ravenscroft G, Rendu J, de Winter JM, Klinge L, Beggs AH, North KN, Ottenheijm CA, Clarke NF.
Hum Mol Genet 24(22):6278-92. doi: 10.1093/hmg/ddv334. Epub 2015 Aug 24. 2015
4TPM3
Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3.
Amano Y, Ishikawa R, Sakatani T, Ichinose J, Sunohara M, Watanabe K, Kage H, Nakajima J, Nagase T, Ohishi N, Takai D.
Biochem Biophys Res Commun 457(3):457-60. doi: 10.1016/j.bbrc.2015.01.014. Epub 2015 Jan 14. 2015
5TPM3
Non-muscle tropomyosin (Tpm3) is crucial for asymmetric cell division and maintenance of cortical integrity in mouse oocytes.
Jang WI, Jo YJ, Kim HC, Jia JL, Namgoong S, Kim NH.
Cell Cycle 13(15):2359-69. doi: 10.4161/cc.29333. 2014
6NEM1, NEM4, TPM2, TPM3
Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
Marttila M, Lehtokari VL, Marston S, Nyman TA, Barnerias C, Beggs AH, Bertini E, Ceyhan-Birsoy O, Cintas P, Gerard M, Gilbert-Dussardier B, Hogue JS, Longman C, Eymard B, Frydman M, Kang PB, Klinge L, Kolski H, Lochmüller H, Magy L, Manel V, Mayer M, Mercuri E, North KN, Peudenier-Robert S, Pihko H, Probst FJ, Reisin R, Stewart W, Taratuto AL, de Visser M, Wilichowski E, Winer J, Nowak K, Laing NG, Winder TL, Monnier N, Clarke NF, Pelin K, Grönholm M, Wallgren-Pettersson C.
Hum Mutat 35(7):779-90. doi: 10.1002/humu.22554. Epub 2014 May 1. 2014
7NEM1, TPM3
Novel TPM3 mutation in a family with cap myopathy and review of the literature.
Schreckenbach T, Schröder JM, Voit T, Abicht A, Neuen-Jacob E, Roos A, Bulst S, Kuhl C, Schulz JB, Weis J, Claeys KG.
Neuromuscul Disord 24(2):117-24. doi: 10.1016/j.nmd.2013.10.002. Epub 2013 Oct 23. Review. 2014
8TPM3
Tropomyosin regulates cell migration during skin wound healing.
Lees JG, Ching YW, Adams DH, Bach CT, Samuel MS, Kee AJ, Hardeman EC, Gunning P, Cowin AJ, O'Neill GM.
J Invest Dermatol 133(5):1330-9. doi: 10.1038/jid.2012.489. Epub 2013 Jan 10. 2013
9STOML2, TMOD3, TPM3
Identification and validation of novel serum markers for early diagnosis of endometriosis.
Gajbhiye R, Sonawani A, Khan S, Suryawanshi A, Kadam S, Warty N, Raut V, Khole V.
Hum Reprod 27(2):408-17. doi: 10.1093/humrep/der410. Epub 2011 Dec 8. 2012
10NEM1, NEM4, TPM2, TPM3
Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms.
Ochala J, Gokhin DS, Pénisson-Besnier I, Quijano-Roy S, Monnier N, Lunardi J, Romero NB, Fowler VM.
Hum Mol Genet 21(20):4473-85. Epub 2012 Jul 13. 2012
11TPM1, TPM3
Functional structure of the promoter regions for the predominant low molecular weight isoforms of tropomyosin in human kidney cells.
Savill SA, Leitch HF, Harvey JN, Thomas TH.
J Cell Biochem 113(11):3576-86. doi: 10.1002/jcb.24236. 2012
12TPM3
Tropomyosin isoform 3 promotes the formation of filopodia by regulating the recruitment of actin-binding proteins to actin filaments.
Creed SJ, Desouza M, Bamburg JR, Gunning P, Stehn J.
Exp Cell Res 317(3):249-61. doi: 10.1016/j.yexcr.2010.10.019. Epub 2010 Oct 29. 2011
13CFTD3, TPM3
Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.
Munot P, Lashley D, Jungbluth H, Feng L, Pitt M, Robb SA, Palace J, Jayawant S, Kennet R, Beeson D, Cullup T, Abbs S, Laing N, Sewry C, Muntoni F.
Neuromuscul Disord 20(12):796-800. Epub 2010 Oct 14. 2010
14TPM3
A cytoskeletal tropomyosin can compromise the structural integrity of skeletal muscle.
Kee AJ, Gunning PW, Hardeman EC.
Cell Motil Cytoskeleton 66(9):710-20. doi: 10.1002/cm.20400. 2009
15NEM1, TPM3
Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin.
Lehtokari VL, Pelin K, Donner K, Voit T, Rudnik-Schöneborn S, Stoetter M, Talim B, Topaloglu H, Laing NG, Wallgren-Pettersson C.
Eur J Hum Genet 16(9):1055-61. Epub 2008 Apr 2. 2008
16TPM1, TPM2, TPM3, TPM4
Human tropomyosin isoforms in the regulation of cytoskeleton functions.
Lin JJ, Eppinga RD, Warren KS, McCrae KR.
Adv Exp Med Biol 644:201-22. Review. 2008
17TPM1, TPM2, TPM3, TPM4
Tropomyosins in skeletal muscle diseases.
Kee AJ, Hardeman EC.
Adv Exp Med Biol 644:143-57. Review. 2008
18NEM1, TPM3
Mutations in TPM3 are a common cause of congenital fiber type disproportion.
Clarke NF, Kolski H, Dye DE, Lim E, Smith RL, Patel R, Fahey MC, Bellance R, Romero NB, Johnson ES, Labarre-Vila A, Monnier N, Laing NG, North KN.
Ann Neurol 63(3):329-37. 2008
19TPM3, TTC9
Tetratricopeptide repeat domain 9A is an interacting protein for tropomyosin Tm5NM-1.
Cao S, Ho GH, Lin VC.
BMC Cancer 8:231. doi: 10.1186/1471-2407-8-231. 2008
20ACOT2, AFAP1L1, ALG11, ANKS1A, ARMC6, ARPC1A, ARPC3, ARPC5L, ATG10, ATP5L, BAZ1A, BCAS2, C2orf44, CAPZA1, CAPZA2, CCDC47, CERS2, CMBL, CPSF2, CSTF3, CXorf56, EXT2, FAF2, FBXO4, FIBP, GLRX3, GPS1, GSKIP, INPP5K, KPNA4, KRT31, KRT32, KRT33A, KRT33B, KRT34, KRT36, LUC7L2, MAGED1, MED7, MMS22L, MPRIP, MPRIP, MRCL3, NAA25, NDN, NPEPPS, NRDE2, OLA1, ORCTL3, OSTF1, PH4B, PIP5K1B, PKIG, PMVK, PSMC1, PSMC2, PSPH, RAB11FIP1, RBX1, RNF219, RO60, RPS14, SF3B14, SF3B2, SFRS12, STK25, TLK2, TONSL, TPM3, TRMT112, TSPAN17, TWF2, UBE2M, UNC45A, UQCRC1, WRAP73, XPO7, ZRANB2
Large-scale mapping of human protein-protein interactions by mass spectrometry.
Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D.
Mol Syst Biol 3:89. Epub 2007 Mar 13. 2007
21NEM1, TPM3
A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study.
Pénisson-Besnier I, Monnier N, Toutain A, Dubas F, Laing N.
Neuromuscul Disord 17(4):330-7. Epub 2007 Mar 21. 2007
22PDGFRB, TPM3
TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemia.
Rosati R, La Starza R, Luciano L, Gorello P, Matteucci C, Pierini V, Romoli S, Crescenzi B, Rotoli B, Martelli MF, Pane F, Mecucci C.
Leukemia 20(9):1623-4. Epub 2006 Jul 13. No abstract available. 2006
23ALK, ATIC, CLTC, MSN, MYH9, RNF213, TFG, TPM3, TPM4
Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma.
Lamant L, Gascoyne RD, Duplantier MM, Armstrong F, Raghab A, Chhanabhai M, Rajcan-Separovic E, Raghab J, Delsol G, Espinos E.
Genes Chromosomes Cancer 37(4):427-32. 2003
24TPM3
Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer.
Lin JL, Geng X, Bhattacharya SD, Yu JR, Reiter RS, Sastri B, Glazier KD, Mirza ZK, Wang KK, Amenta PS, Das KM, Lin JJ.
Gastroenterology 123(1):152-62. 2002
25NEM1, TPM3
Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy.
Wattanasirichaigoon D, Swoboda KJ, Takada F, Tong HQ, Lip V, Iannaccone ST, Wallgren-Pettersson C, Laing NG, Beggs AH.
Neurology 59(4):613-7. 2002
26NEM1, TPM3
A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy.
Corbett MA, Robinson CS, Dunglison GF, Yang N, Joya JE, Stewart AW, Schnell C, Gunning PW, North KN, Hardeman EC.
Hum Mol Genet 10(4):317-28. 2001
27BLOM7, HAX1, MCKD1, SYT11, TPM3, UBAP2L
Refinement of the gene locus for autosomal dominant medullary cystic kidney disease type 1 (MCKD1) and construction of a physical and partial transcriptional map of the region.
Fuchshuber A, Kroiss S, Karle S, Berthold S, Huck K, Burton C, Rahman N, Koptides M, Deltas C, Otto E, Ruschendorf F, Feest T, Hildebrandt F.
Genomics 72(3):278-84. 2001
28NEM1, TPM3
Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy.
Tan P, Briner J, Boltshauser E, Davis MR, Wilton SD, North K, Wallgren-Pettersson C, Laing NG.
Neuromuscul Disord 9(8):573-9. 1999
29NTRK1, TPM3
A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Butti MG, et al.
Genomics 28 : 15-24. 1995
30TPM3, NEM1
Assignment of the human alpha-tropomyosin gene TPM3 to 1q22-q23 by fluorescence in situ hybridization.
Wilton SD, et al.
Cytogenet Cell Genet 68 : 122-124. 1995
31NEM1, TPM3
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy.
Laing NG, et al.
Nat Genet 9 : 75-79. 1995
32TPM3
TaqI RFLP of the human tropomyosin gene (TPM3) involved in the generation of the TRK oncogene.
Michieli P, et al.
Nucleic Acids Res 19 : 4796. 1991
33TPM3
The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31.
Radice P, et al.
Oncogene 6 : 2145-2148. 1991